2,5-di-tert-butylhydroquinone has been researched along with lithium chloride in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Benitez, R; Chen, SR; Clark, RB; Duff, HJ; Guo, A; Guo, J; Hove-Madsen, L; Jones, PP; Semeniuk, L; Song, LS; Vallmitjana, A; Wang, R; Zhong, X; Zhou, Q | 1 |
1 other study(ies) available for 2,5-di-tert-butylhydroquinone and lithium chloride
| Article | Year |
|---|---|
Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Caffeine; Calcium Signaling; Calcium-Binding Proteins; Calcium-Transporting ATPases; Cells, Cultured; Disease Models, Animal; Electrocardiography; Hydroquinones; Isoproterenol; Lithium Chloride; Mice; Mice, Knockout; Mutation, Missense; Myocytes, Cardiac; Patch-Clamp Techniques; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Tachycardia, Ventricular; Ultrasonography | 2013 |